Stay updated on PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer's displayed site revision changes from v3.7.0 to v3.7.1. The page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T16:42:26.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study details, indicating that the study record is temporarily inaccessible. Users cannot view the study information on this URL until access is restored.
    Difference
    18%
    Check dated 2026-09-22T21:40:48.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page now shows revision tag v3.7.0, replacing the previous v3.6.6. This indicates an update to the page version without changes to the study details shown.
    Difference
    0.1%
    Check dated 2026-09-15T20:59:08.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.5 to v3.6.6 on the page, indicating a minor update to the page's revision history. This update does not alter the study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-09-01T18:17:34.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The revision tag at the bottom of the page updated to Revision: v3.6.5, replacing v3.6.4. This reflects a minor platform update and does not change the study content.
    Difference
    0.1%
    Check dated 2026-08-11T13:45:56.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Revision: v3.6.4 replaces v3.6.3 on the page, reflecting a minor metadata update. This does not change the study content or visible details.
    Difference
    0.1%
    Check dated 2026-07-28T03:05:59.000Z thumbnail image

Stay in the know with updates to PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PRS-343 & Atezolizumab in HER2+ Solid Tumors Clinical Trial page.